Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new consolidated Locations section lists participating sites across California, Colorado, Kentucky, Michigan, New York, Pennsylvania, South Dakota, Texas, and Utah, replacing the prior per-state headings. The footer revision note also updates from v3.3.2 to v3.3.3.
    Difference
    0.9%
    Check dated 2025-12-17T19:45:42.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed on the page, replacing v3.2.0. This update is limited to a software/version change and does not alter study details or other user-visible content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-26T13:59:24.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Removed a general government funding status notice from the page; this banner is administrative and does not affect trial details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T08:40:00.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The changes are limited to minor formatting and small textual tweaks; core study content such as design, eligibility criteria, and endpoints remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:24:16.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Update to v3.2.0 with an important government-operating-status notice; removal of two GARD resources (Carcinoma of esophagus and Cutaneous neuroendocrine carcinoma) from the catalog.
    Difference
    4%
    Check dated 2025-10-06T16:02:53.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.1.0 and removes the topic term 'Ovarian cancer' from the content, signaling a scope/content update with versioned revision rather than a data-heavy update.
    Difference
    0.2%
    Check dated 2025-09-29T09:57:45.000Z thumbnail image

Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.